NEWS
Trans- NIH updates from product development and small business programs.
View a list of upcoming events and past event recordings and resources.
July 2022
15
Jul
America's Seed Fund Week events, SBIR & STTR Webinar, and more
14
Jul
The National Institute on Drug Abuse (NIDA), one of the components of the National Institutes of Health (NIH), is announcing the “Product Prototypes to Combat Drug Craving” Challenge. The Challenge goal is to solicit working prototypes of multifaceted products that will help with drug craving in people who experience substance use problems or with substance use disorder (SUD). Ideally, these multifaceted product prototypes would combine several different tools or features to address drug craving, providing long-term, on-demand, and personalized comprehensive assistance that can ultimately reduce the likelihood of return to use (also known as recurrence). NIDA expects that the Challenge will inspire many different product prototypes to help people address their drug cravings and prevent recurrence of drug use.
The Challenge will offer up to two awards: up to $50,000 for first place and up to $35,000 for second place entries, as well as up to three honorable mention awards of up to $5,000 each. The Challenge total purse is up to $100,000.
Submissions are accepted until 8/31/22 at 6:00 p.m. ET.
The Challenge will offer up to two awards: up to $50,000 for first place and up to $35,000 for second place entries, as well as up to three honorable mention awards of up to $5,000 each. The Challenge total purse is up to $100,000.
Submissions are accepted until 8/31/22 at 6:00 p.m. ET.
14
Jul
The National Institute of Mental Health (NIMH) supports a wide range of compelling science through its Small Business Innovation Research (SBIR) program. With these funds, NIMH supports research aimed at everything from novel clinical approaches to exciting new technologies and engaging educational tools. One area of NIMH-supported science that has become particularly interesting is biomarker development. Read the NIMH Director's message to learn more.
June 2022
27
Jun
The NIH TABA Program helps small businesses identify and address their most pressing product development needs. And now, if eligible, you can submit a request for a FREE Needs Assessment Report that provides a third party, unbiased assessment of your project’s progress in 4 technical and business areas that are critical to success in the competitive healthcare marketplace.
Your company is eligible to participate if your Phase I NIH SBIR or STTR (grant, contract, or Fast-Track)
is active or was active within the past two years, AND
was not awarded TABA funding within the Phase I award budget, AND
has not already received a TABA Needs Assessment Report or NICHE Assessment for the same Phase I project.
Please note, selection is not guaranteed. The TABA Needs Assessment is performed by RTI Innovation Advisors through a contract with the NIH.
Questions? Email us at SEEDinfo@nih.gov.
Your company is eligible to participate if your Phase I NIH SBIR or STTR (grant, contract, or Fast-Track)
is active or was active within the past two years, AND
was not awarded TABA funding within the Phase I award budget, AND
has not already received a TABA Needs Assessment Report or NICHE Assessment for the same Phase I project.
Please note, selection is not guaranteed. The TABA Needs Assessment is performed by RTI Innovation Advisors through a contract with the NIH.
Questions? Email us at SEEDinfo@nih.gov.
27
Jun
NOT-ES-22-009 (R41/R42 Clinical Trial Optional) focuses on the development of innovative tools, technologies, and methodologies on climate change and health that will significantly increase the potential for understanding the complex drivers of adverse health outcomes and enable effective and impactful interventions.
Related funding opportunity announcements:
PA-22-178
PA-22-179
This notice applies to due dates on or after September 5, 2022 and subsequent receipt dates through April 5, 2023.
Related funding opportunity announcements:
PA-22-178
PA-22-179
This notice applies to due dates on or after September 5, 2022 and subsequent receipt dates through April 5, 2023.
27
Jun
Applicants are encouraged to review the new 2022 SBIR and STTR Omnibus Funding Opportunities (FOAs). These FOAs encourage small businesses to submit grant applications to NIH, CDC, and FDA for innovative ideas across the HHS mission space.
Each Institute or Center’s mission, unique features, and staff contacts are provided in the updated Program Descriptions and Research Topics.
Each Institute or Center’s mission, unique features, and staff contacts are provided in the updated Program Descriptions and Research Topics.
27
Jun
Course on Innovation and Entrepreneurship for Substance Use Researchers, Updates SBIR & STTR Policy
27
Jun
NOT-ES-22-010 (R43/R44 Clinical Trial Optional) focuses on the development of innovative tools, technologies, and methodologies on climate change and health that will significantly increase the potential for understanding the complex drivers of adverse health outcomes and enable effective and impactful interventions.
Related funding opportunity announcements:
PA-22-176
PA-22-177
This notice applies to due dates on or after September 5, 2022 and subsequent receipt dates through April 5, 2023.
Related funding opportunity announcements:
PA-22-176
PA-22-177
This notice applies to due dates on or after September 5, 2022 and subsequent receipt dates through April 5, 2023.
27
Jun
NOT-OD-22-143: When a legal action (i.e., merger, acquisition, successor in interest) takes place that changes the organizational status of a small business concern such that the small business is no longer eligible for SBIR/STTR programs, existing SBIR & STTR awards to the organization cannot be awarded additional funds, including noncompeting continuations and supplements, and the organization would no longer be eligible for any new SBIR/STTR grants.
14
Jun
TABA Needs Assessment Re-Issued, 2022 Funding Opportunities available
